Abstract
Background
It has been known that anesthetic adjuvants such as dexamethasone or ketamine might change mood. This study aimed to investigate the effects of a single dose of each drug individually along with their combined usage on postoperative mood changes in patients undergoing gynecologic surgery.
Methods
Two hundred ninety-seven patients randomly allocated were divided into three groups. Group K (n = 99) received a single dose of ketamine (0.5 mg/kg iv); group D (n = 99) received a single dose of dexamethasone (0.1 mg/kg iv), and group KD (n = 99) received both ketamine (0.5 mg/kg iv) and dexamethasone (0.1 mg/kg iv) at 5 min after the induction of anesthesia. A change in the patient health questionnaire (PHQ)-9 scores on the first and third day after surgery, the duration of anesthesia, the postoperative visual analog scale (VAS) for pain, and the patient controlled analgesia (PCA) consumption were evaluated.
Results
Groups K and KD showed a significant reduction in PHQ-9 score on both the first and third day after surgery compared with those recorded preoperatively and in group D (P < 0.01). There were no differences in the group D PHQ-9 scores pre- and post-operatively. The VAS for pain 24 h after surgery and the PCA consumption in group KD decreased significantly compared to the other two groups (P < 0.05).
Conclusions
A single dose of ketamine (0.5 mg/kg) with or without combination with dexamethasone (0.1 mg/kg) give iv 5 min after induction of general anesthetic produced significant improvement in the postoperative mood scores. A single intravenous dose of dexamethasone (0.1 mg/kg) alone did not change postoperative mood scores. The VAS for pain 24 h after surgery and the PCA consumption was significantly lower in patients who received combination of both drugs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abdallah CG, Sanacora G, Duman RS, Krystal JH (2015) Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics. Annu Rev Med 66:509–523
Arana GW, Santos AB, Laraia MT, McLeod-Bryant S, Beale MD, Rames LJ, Roberts JM, Dias JK, Molloy M (1995) Dexamethasone for the treatment of depression: a randomized, placebo-controlled, double-blind trial. Am J Psychiatry 152:265–267
Benyamin RM, Vallejo R, Kramer J, Rafeyan R (2008) Corticosteroid induced psychosis in the pain management setting. Pain Physician 11:917–920
Bhatt S, Shukla P, Raval J, Goswami S (2016) Role of aspirin and dexamethasone against experimentally induced depression in rats. Basic Clin Pharmacol Toxicol 119:10–18
Brown ES (2009) Effects of glucocorticoids on mood, memory, and the hippocampus. Treatment and preventive therapy. Ann N Y Acad Sci 1179:41–55
Cameron IM, Crawford JR, Lawton K, Reid IC (2008) Psychometric comparison of PHQ-9 and HADS for measuring depression severity in primary care. Br J Gen Pract 58:32–36
Ciriaco M, Ventrice P, Russo G, Scicchitano M, Mazzitello G, Scicchitano F, Russo E (2013) Corticosteroid-related central nervous system side effects. J Pharmacol Pharmacother 4:S94–S98
Dinan TG, Lavelle E, Cooney J, Burnett F, Scott L, Dash A, Thakore J, Berti C (1997) Dexamethasone augmentation in treatment-resistant depression. Acta Psychiatr Scand 95:58–61
Garay RP, Zarate CA Jr, Charpeaud T, Citrome L, Correll CU, Hameg A, Llorca PM (2017) Investigational drugs in recent clinical trials for treatment-resistant depression. Expert Rev Neurother 17:593–609
Haddad M, Walters P, Phillips R, Tsakok J, Williams P, Mann A, Tylee A (2013) Detecting depression in patients with coronary heart disease: a diagnostic evaluation of the PHQ-9 and HADS-D in primary care, findings from the UPBEAT-UK study. PLoS One 8:e78493
Hu YD, Xiang YT, Fang JX, Zu S, Sha S, Shi H, Ungvari GS, Correll CU, Chiu HFK, Xue Y, Tian TF, Wu AS, Ma X, Wang G (2016) Single iv ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study. Psychol Med 46:623–635
Jiang M, Wang MH, Wang XB, Liu L, Wu JL, Yang XL, Liu XR, Zhang CX (2016) Effect of intraoperative application of ketamine on postoperative depressed mood in patients undergoing elective orthopedic surgery. J Anesth 30:232–237
Mjellem N, Lund A, Hole K (1993) Reduction of NMDA-induced behaviour after acute and chronic administration of desipramine in mice. Neuropharmacology 32:591–595
Mohtadi A, Nesioonpour S, Salari A, Akhondzadeh R, Masood Rad B, Aslani SM (2014) The effect of single-dose administration of dexamethasone on postoperative pain in patients undergoing laparoscopic cholecystectomy. Anesth Pain Med 4:e17872
Pakarinen M, Tuomainen I, Koivumaa-Honkanen H, Sinikallio S, Lehto SM, Airaksinen O, Viinamäki H, Aalto T (2016) Life dissatisfaction is associated with depression and poorer surgical outcomes among lumbar spinal stenosis patients: a 10-year follow-up study. Int J Rehabil Res 39:291–295
Paul IA, Nowak G, Layer RT, Popik P, Skolnick P (1994) Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. J Pharmacol Exp Ther 269:95–102
Ponto LB, Perry PJ, Liskow BI, Seaba HH (1977) Drug therapy reviews: tricyclic antidepressant and monoamine oxidase inhibitor combination therapy. Am J Hosp Pharm 34:954–961
Safavi M, Honarmand A, Habibabady MR, Baraty S, Aghadavoudi O (2012) Assessing intravenous ketamine and intravenous dexamethasone separately and in combination for early oral intake, vomiting and postoperative pain relief in children following tonsillectomy. Med Arh 66:111–115
Salvadore G, Singh JB (2013) Ketamine as a fast acting antidepressant: current knowledge and open questions. CNS Neurosci Ther 19:428–436
Tharin S, Mayer E, Krishnaney A (2012) Lumbar microdiscectomy and lumbar decompression improve functional outcomes and depression scores. Evid Based Spine Care J 3:65–66
Urban-Baeza A, Zárate-Kalfópulos B, Romero-Vargas S, Obil-Chavarría C, Brenes-Rojas L, Reyes-Sánchez A (2015) Influence of depression symptoms on patient expectations and clinical outcomes in the surgical management of spinal stenosis. J Neurosurg Spine 22:75–79
Wan LB, Levitch CF, Perez AM, Brallier JW, Iosifescu DV, Chang LC, Foulkes A, Mathew SJ, Charney DS, Murrough JW (2015) Ketamine safety and tolerability in clinical trials for treatment-resistant depression. J Clin Psychiatry 76:247–252
Funding
This study was supported by Wonkwang University in 2018.
Author information
Authors and Affiliations
Contributions
C Lee: study design, data collection, data analysis, patient recruitment, revising the article critically for important intellectual content, and final approval of the version to be submitted.
J Lee: data collection, patient recruitment, and final approval of the version to be submitted.
J Hwang: study design, data analysis, revising the article critically for important intellectual content, and final approval of the version to be submitted.
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, C., Lee, J., Lee, G. et al. The effects of a combination of intravenous dexamethasone and ketamine on postoperative mood in patients undergoing laparoscopically assisted-gynecologic surgery. Psychopharmacology 235, 2417–2422 (2018). https://doi.org/10.1007/s00213-018-4939-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-018-4939-z